NB-UVB

DEVICE15 trials

Conditions

Atopic DermatitisChronic Plaque PsoriasisKeloidNon-segmental VitiligoPlaque PsoriasisPsoriasisPsoriasis VulgarisPsoriatic Conditions

Phase 1

To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris

CompletedNCT00050661

Rockefeller UniversityPsoriasis

Start: 1997-10-31End: 2008-04-30Updated: 2009-03-25

The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo

NCT03234673

Assiut UniversityVitiligo Vulgaris

Start: 2017-08-31End: 2019-01-31Target: 30Updated: 2017-08-01

Phase 2

Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo

CompletedNCT01382589

Clinuvel Pharmaceuticals LimitedVitiligo

Start: 2011-09-30End: 2012-12-31Updated: 2013-03-22

Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial

NCT04071106

Zagazig UniversityPsoriasis

Start: 2019-09-01End: 2019-12-31Target: 50Updated: 2019-08-28

Phase 4

Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

CompletedNCT00110981

AmgenPsoriasis

Start: 2005-03-31End: 2006-03-31Updated: 2013-05-24

Study of the Efficacy of Early Intervention With Secukinumab 300 mg s.c. Compared to Narrow-band UVB in Patients With New-onset Moderate to Severe Plaque Psoriasis

CompletedNCT03020199

Novartis PharmaceuticalsPlaque Psoriasis

Start: 2017-03-27End: 2023-06-16Updated: 2025-01-28

Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo

NCT03199664

South Valley UniversityVitiligo

Start: 2017-09-01End: 2018-12-01Target: 100Updated: 2018-09-06

Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation

NCT04811326

Shaimaa Fawzy Abdel-rady Abdel-latifNon-segmental Vitiligo

Start: 2021-01-13End: 2024-03-13Target: 150Updated: 2023-08-09

Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo Patients

Enrolling by invitationNCT06593197

Dow University of Health SciencesVitiligo

Start: 2025-01-01End: 2027-03-30Target: 30Updated: 2025-03-11

Unknown Phase

Narrowband UVB Phototherapy in the Treatment of Psoriasis Vulgaris

TerminatedNCT00844363

Rockefeller UniversityChronic Plaque Psoriasis

Start: 2008-11-30End: 2011-05-31Target: 20Updated: 2011-06-30

Narrow-band (NB)-UVB vs. Bath-PUVA and NB-UVB Plus Salt Water Baths in Atopic Dermatitis

TerminatedNCT01402414

Ruhr University of BochumAtopic Dermatitis

Start: 2011-04-30End: 2014-02-28Updated: 2014-02-21

Improving Keloids Using Targeted Ultraviolet-B Irradiation

CompletedNCT03160053

Johns Hopkins UniversityKeloid

Start: 2015-06-23End: 2018-06-15Updated: 2018-06-19

The Effect of NB-UVB on Interleukin-36 Levels in Psoriasis

NCT03526705

Cairo UniversityPsoriasis

Start: 2019-07-15End: 2020-01-15Target: 25Updated: 2019-07-23

Effect Narrow-Band UVB Radiations

CompletedNCT05647187

South Valley UniversityPsoriasis Vulgaris, UVB Phototherapy Burn

Start: 2020-01-01End: 2021-10-01Updated: 2022-12-12

Evaluation The Effect of NB-UVB and Methotrexate on The Level of Serum Gelsolin in Psoriatic Patients

RecruitingNCT06712238

Aswan UniversityPsoriatic Conditions

Start: 2024-06-10End: 2025-06-10Target: 48Updated: 2024-12-02

Related Papers

Secukinumab demonstrates superiority over narrow‐band ultraviolet B phototherapy in new‐onset moderate to severe plaque psoriasis patients: Week 52 results from the <scp>STEPIn</scp> study

Journal of the European Academy of Dermatology and Venereology2023-01-0632 citations

Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study.

2018-07-1538 citations